http://books.google.com/books?id=Sn...i=book_result&ct=result&resnum=1#PRA1-PA35,M1
http://http://books.google.com/books?id=SnwB_fmjr2MC&pg=RA1-PA34&lpg=RA1-PA34&dq=antidepressants+CYP2D6+interaction+with+Codeine&source=bl&ots=3z_UR1ifT-&sig=2_ijF3G4Zlb-Alx7kIubm0RkoTA&hl=en&ei=-xwCSoH4G5nNjAeanOWGBw&sa=X&oi=book_result&ct=result&resnum=1#PRA1-PA35,M1
Another I had a look at above.
http://http://www3.interscience.wiley.com/journal/75500464/abstract
^^
"Based on these parameters, selecting an antidepressant medication, such as venlafaxine, that has a low potential for drug interactions at the Cytochrome P450 (CYP) enzyme system, and is easy to monitor and dose, facilitate successful treatment of patients. Venlafaxine has been evaluated in clinical studies that demonstrate low to negligible drug interaction potential at CYP2D6, CYP1A2, CYP2C19, and CYP3A4. Its short half-life and time to steady-state, when coupled with the extended release characteristics of the preferred dosage formulation allow for once daily dosing and rapid attainment of therapeutic effects".
http://http://pn.psychiatryonline.org/cgi/content/full/43/6/1-a
The above sys that Venlefaxine inhibits CYP2d6 so weakly that it would be like you were not taking one.
http://http://www.cnsspectrums.com/aspx/articledetail.aspx?articleid=1085
^ this one quotes Sertraline somewhere as being weak at low doses i.e. 50mg but higher doses seem to inhibit CYP2d6 somewhat highly.
http://http://books.google.com/books?id=SnwB_fmjr2MC&pg=RA1-PA34&lpg=RA1-PA34&dq=antidepressants+CYP2D6+interaction+with+Codeine&source=bl&ots=3z_UR1ifT-&sig=2_ijF3G4Zlb-Alx7kIubm0RkoTA&hl=en&ei=-xwCSoH4G5nNjAeanOWGBw&sa=X&oi=book_result&ct=result&resnum=1#PRA1-PA35,M1
Another I had a look at above.
http://http://www3.interscience.wiley.com/journal/75500464/abstract
^^
"Based on these parameters, selecting an antidepressant medication, such as venlafaxine, that has a low potential for drug interactions at the Cytochrome P450 (CYP) enzyme system, and is easy to monitor and dose, facilitate successful treatment of patients. Venlafaxine has been evaluated in clinical studies that demonstrate low to negligible drug interaction potential at CYP2D6, CYP1A2, CYP2C19, and CYP3A4. Its short half-life and time to steady-state, when coupled with the extended release characteristics of the preferred dosage formulation allow for once daily dosing and rapid attainment of therapeutic effects".
http://http://pn.psychiatryonline.org/cgi/content/full/43/6/1-a
The above sys that Venlefaxine inhibits CYP2d6 so weakly that it would be like you were not taking one.
http://http://www.cnsspectrums.com/aspx/articledetail.aspx?articleid=1085
^ this one quotes Sertraline somewhere as being weak at low doses i.e. 50mg but higher doses seem to inhibit CYP2d6 somewhat highly.

